Metabolic diseases present particular difficulty for clinicians because they are often present for years before becoming clinically apparent. Clinical predictors of future diabetes mellitus (DM) are imperfect. The identification of individuals at ris is of particular importance because the delay or prevention of type 2 DM is possible via both behavioral and pharmacological interventions. In the first 3 1/2 years of this grant, we applied our mass spectrometry-based metabolomics platform to identify and validate metabolite profiles of those destined to develop overt DM. The findings were based on longitudinal follow-up in two prospective cohorts, the Framingham Heart Study and the Malmo Diet and Cancer Study. The strongest individual predictors of future DM included branched chain amino acids, aromatic amino acids, and 2-aminoadipic acid (a lysine degradation product). These metabolites were elevated up to 12 years before the onset of DM in glucose-tolerant individuals at baseline, and predicted DM above and beyond clinical risk factors and biochemical markers. These findings suggest that metabolite profiling could play a role in DM prevention strategies. To test this hypothesis, we will leverage the unique resources of the Diabetes Prevention Program (DPP), a multi-center RCT of interventions to prevent or delay the onset of DM in individuals at high-risk of the disease.
In Aim 1, we will assess the relation of baseline metabolites with incident DM, and test interactions of metabolites with therapy.
In Aim 2, we will determine whether lifestyle and pharmacologic interventions lead to changes in selected metabolites.
In Aim 3, we will investigate relations of metabolites with insulin sensitivity and insulin secretion measures. We will perform cross-sectional and longitudinal analyses to investigate the relation of metabolites with measures of insulin sensitivity and secretion. The DPP represents an ideal setting in which to conduct the investigations for the next phase of our grant, examining novel predictors of DM and their potential role in personalizing therapeutic interventions.

Public Health Relevance

Current treatments for diabetes mellitus (DM) are only partially successful, in part because they are based on limited knowledge of its root causes. Furthermore, there is no way to accurately predict who will develop DM, thus limiting our ability to intervene effectively. Our goal is to use new blood chemical profiling approaches to illuminate our understanding of the underlying disease mechanisms in DM, to identify novel predictors of DM, and to evaluate whether the predictors can help to personalize therapeutic interventions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
7R01DK081572-06
Application #
8517689
Study Section
Special Emphasis Panel (ZDK1-GRB-N (M8))
Program Officer
Castle, Arthur
Project Start
2008-08-01
Project End
2014-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
6
Fiscal Year
2013
Total Cost
$467,544
Indirect Cost
$67,003
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Cavallaro, Nicole Landa; Garry, Jamie; Shi, Xu et al. (2016) A pilot, short-term dietary manipulation of branched chain amino acids has modest influence on fasting levels of branched chain amino acids. Food Nutr Res 60:28592
Ejaz, Asma; Martinez-Guino, Laura; Goldfine, Allison B et al. (2016) Dietary Betaine Supplementation Increases Fgf21 Levels to Improve Glucose Homeostasis and Reduce Hepatic Lipid Accumulation in Mice. Diabetes 65:902-12
Ho, Jennifer E; Larson, Martin G; Ghorbani, Anahita et al. (2016) Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes. PLoS One 11:e0148361
Ko, Darae; Riles, Eric M; Marcos, Ernaldo G et al. (2016) Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study). Am J Cardiol 118:1493-1496
Elmariah, Sammy; Farrell, Laurie A; Daher, Maureen et al. (2016) Metabolite Profiles Predict Acute Kidney Injury and Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement. J Am Heart Assoc 5:e002712
Walford, Geoffrey A; Ma, Yong; Clish, Clary et al. (2016) Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention Program. Diabetes 65:1424-33
Lewis, Gregory D; Ngo, Debby; Hemnes, Anna R et al. (2016) Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary Hypertension. J Am Coll Cardiol 67:174-89
Magnusson, Martin; Wang, Thomas J; Clish, Clary et al. (2015) Dimethylglycine Deficiency and the Development of Diabetes. Diabetes 64:3010-6
Yu, Bing; Li, Alexander H; Muzny, Donna et al. (2015) Association of Rare Loss-Of-Function Alleles in HAL, Serum Histidine: Levels and Incident Coronary Heart Disease. Circ Cardiovasc Genet 8:351-5
Cheng, Susan; Larson, Martin G; McCabe, Elizabeth L et al. (2015) Distinct metabolomic signatures are associated with longevity in humans. Nat Commun 6:6791

Showing the most recent 10 out of 47 publications